Pevonedistat 1014: A Randomized, Crossover Phase 1 Study to Evaluate the Effects of Pevonedistat on the QTc Interval in Patients With Advanced Solid Tumors

February 24, 2019
https://clinicaltrials.gov/ct2/results?id=NCT03330106
Cancer - Gynecologic/ Ovarian, Solid Tumors
Principal Investigator: Ding Wang, MD
Cancer, Phase 1, Phase I, Solid Tumors, Solid Tumors Neoplasm, Advanced
Open